FGFR4 Arg388 allele correlates with tumour thickness and FGFR4 protein expression with survival of melanoma patients
S. Streit(Max Planck Institute of Biochemistry), Carola Berking(Universitätsklinikum Erlangen)
Cited by 78
Related Papers
Selumetinib in Combination With Dacarbazine in Patients With Metastatic Uveal Melanoma: A Phase III, Multicenter, Randomized Trial (SUMIT)
|Journal of Clinical Oncology|2018|274
Skin cancer classification via convolutional neural networks: systematic review of studies involving human experts
|European Journal of Cancer|2021|246
Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a multicentre, randomized, observer-blind phase III study in comparison with a registered methyl-5-aminolaevulinate cream and placebo
|British Journal of Dermatology|2011|181
Sequence-dependent cross-resistance of combined radiotherapy plus BRAFV600E inhibition in melanoma
|European Journal of Cancer|2019|26
Results of COLUMBUS Part 2: A Phase 3 Trial of Encorafenib (ENCO) Plus Binimetinib (BINI) Versus ENCO in BRAF - Mutant Melanoma
|Journal Der Deutschen Dermatologischen Gesellschaft|2017|2